Member Info for Sagetrade

RealityHunter, remind us of the II's that have invested in your beloved ODX?

Jealousy is a horrible trait. Anyway, its not how big it is its what you do with it, so dont worry - you'll find that out once you lose your virginity.

RealityHunter - it's never too late to sell ODX and buy AVCT.

Don't be bitter, just because you have a micro ***** and are invested over there - you can change one of those things!

Morning Arnold, don’t forget to take your ADHDA tablets.

Morning Arnold

Is Radiagreen AP / Poundcake?!

You don’t half talk some tosh!

Is it not obvious to people yet? There is clearly not a sovereign test that has met gov performance criteria for mass testing yet.

It’s blindingly obvious that they are waiting on full CV results from Avacta, just wake up and smell the coffee.

Makes no difference to holders here what test you produce, and it may well be that Avactas doesn’t meet the standards either, but it’s pretty bludy obvious what’s going on here and why gov haven’t yet announced what test you and others will be making.

Exactly, the reaction of some is absolutely pathetic. Covid really has brought some absolutely clueless Twat’s into investing.

The guy was an NED who hence had no involvement in the day to day running of the company.

NED’s are often rotated due to governance and I believe he’s been on the board in that role for 7 years which is a long time for a NED.

Lastly, he is 70 so probably approaching retirement.

It’s the ultimate non news and it’s frankly boring that we’re even having to point the blindingly obvious out due to some absolute cretins on this board .

Yes tsales, joining all that smart money from II's you currently have....oh wait....

Re time to TT etc, can you explain why Dr Smith stated "GAD are in a position to manufacture our test immediately" in a recent directors talk interview?

When did I say that speranza...?

I don't think it's news to the well researched that the Mologic test is a poor performer....initial sens was 92% on CE announcement in December 20. The fact they're flogging manufax capacity to us and Aptamer is also a giveaway.

Changes nothing until we receive CE and full CV data. I have confidence it'll be the result we think, but serves no purpose to dress this up as something it's not.

Probably a coincidence, but I did notice the doc is dated 16th Feb - same day our initial results RNS was published.

It's dated 16th Feb pal, cool your engines...

It wasn't, they are a Ltd company so don't have to make any of this available.

Slide 8 with CT values is telling. c90% at CT<25.

Over to you Sir Al.

Hi VC,

Dr Smith specifically stated earlier this week that our affimer binders don't sit in/attach to the region of the virus where ALL the mutations have thus far occurred.

He also stated, that in the unlikely event the current affimer doesn't pick up a specific variant, a new affimer can be produced and be ready to go within the current LFT infrastructure within 4 weeks.

Appreciate your concerns though....

Unless Mologic have done some serious work on their own LFT (I.E. inserted an affimer :) ) then I just don't see how they can be anywhere near the front here at 92% sensitivity....

Totally agree, utter horse****, we are CV'ing at multiple sites, one of which is in the UK and likely PD.

Rolly, crying shame you sold out 10 mins ago then ain't it. You bi-polar?

Tsales - they haven't even commenced clinical validation you absolute tit.

The bigger question for me is where does this leave Mologic's own test?! Appears they have now given capacity to both Avacta and Aptamer Group.

I suggested yesterday that their test has been rejected by UK gov due to not being sensitive enough, seems highly plausible now.

I agree, but the two aren't mutually exclusive! You can have rises and falls off the back of fundamentals and news but still believe in clear support and resistance levels!

Sorry, but I reluctantly disagree. Even for someone with a pretty basic knowledge of TA like myself, c235 does look like a support line.

I think the merits of charting are limited, hence I don't delve too deeply, but silly to dismiss them completely, especially when looking at support and resistance lines.

I think the amount of times the word “if” crops up in that post probably tells you why the majority of PI’s would absolutely snap your hand off at the prospect of £20 a share!